People

Samuel Cohen

Samuel Cohen is CEO and co-founder of Ride Therapeutics and serves on its board. He previously co-founded and led Wren Therapeutics and helped found Transition Bio. His background includes biotechnology investing at Malin, strategy consulting at BCG and biophysical chemistry research at Cambridge. He is also an executive director and co-founder of Transition Bio.